Clinical Approach and Review of Causes of a Chylothorax T ∗ Leonard E
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Chylothorax After Left Side Pneumothorax Surgery Managed by OK-432 Pleurodesis: an Effective Alternative
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Available online at www.sciencedirect.com ScienceDirect Journal of the Chinese Medical Association 77 (2014) 653e655 www.jcma-online.com Case Report Chylothorax after left side pneumothorax surgery managed by OK-432 pleurodesis: An effective alternative Sheng-Yang Huang a, Chou-Ming Yeh b, Chia-Man Chou a,c,*, Hou-Chuan Chen a a Division of Pediatric Surgery, Department of Surgery, Taichung Veterans General Hospital, Taichung, Taiwan, ROC b Taichung Hospital, Ministry of Health and Welfare, Taichung, Taiwan, ROC c National Yang-Ming University School of Medicine, Taipei, Taiwan, ROC Received June 13, 2013; accepted September 23, 2013 Abstract Chylothorax, a relatively rare complication of thoracic surgery, mostly occurs on the right side. We present a 16-year-old male who received thoracoscopic surgery for left spontaneous pneumothorax. Chylothorax developed on the postoperative 2nd day and resolved after diet control on the 4th day. Unfortunately, chylothorax recurred 2 weeks later. Chest drainage and nil per os with total parental nutrition were given but in vain. Thereafter, chemical pleurodesis with OK-432 was performed. Chylothorax resolved on the next day. The relevant literature is reviewed and possible pathogenesis clarified. Copyright © 2014 Elsevier Taiwan LLC and the Chinese Medical Association. All rights reserved. Keywords: chylothorax; pleurodesis; pneumothorax 1. Introduction 2. Case Report Postoperative chylothorax is infrequent but potentially A 16-year-old male patient had the history of left chest pain life-threatening and time-consuming to manage. Associated for 5 days. -
Section 8 Pulmonary Medicine
SECTION 8 PULMONARY MEDICINE 336425_ST08_286-311.indd6425_ST08_286-311.indd 228686 111/7/121/7/12 111:411:41 AAMM CHAPTER 66 EVALUATION OF CHRONIC COUGH 1. EPIDEMIOLOGY • Nearly all adult cases of chronic cough in nonsmokers who are not taking an ACEI can be attributed to the “Pathologic Triad of Chronic Cough” (asthma, GERD, upper airway cough syndrome [UACS; previously known as postnasal drip syndrome]). • ACEI cough is idiosyncratic, occurrence is higher in female than males 2. PATHOPHYSIOLOGY • Afferent (sensory) limb: chemical or mechanical stimulation of receptors on pharynx, larynx, airways, external auditory meatus, esophagus stimulates vagus and superior laryngeal nerves • Receptors upregulated in chronic cough • CNS: cough center in nucleus tractus solitarius • Efferent (motor) limb: expiratory and bronchial muscle contraction against adducted vocal cords increases positive intrathoracic pressure 3. DEFINITION • Subacute cough lasts between 3 and 8 weeks • Chronic cough duration is at least 8 weeks 4. DIFFERENTIAL DIAGNOSIS • Respiratory tract infection (viral or bacterial) • Asthma • Upper airway cough syndrome (postnasal drip syndrome) • CHF • Pertussis • COPD • GERD • Bronchiectasis • Eosinophilic bronchitis • Pulmonary tuberculosis • Interstitial lung disease • Bronchogenic carcinoma • Medication-induced cough 5. EVALUATION AND TREATMENT OF THE COMMON CAUSES OF CHRONIC COUGH • Upper airway cough syndrome: rhinitis, sinusitis, or postnasal drip syndrome • Presentation: symptoms of rhinitis, frequent throat clearing, itchy -
Nutritional Management of Chyle Leaks: an Update
NUTRITION ISSUES IN GASTROENTEROLOGY, SERIES #94 Carol Rees Parrish, R.D., M.S., Series Editor Nutritional Management of Chyle Leaks: An Update Stacey McCray Carol Rees Parrish Chyle leaks are an uncommon but challenging complication for clinicians. Evidence- based guidelines for the management of chyle leaks are lacking. Nutrition therapy is a key component in the care of patients with chyle leaks and can range from primary treatment to adjunctive therapy. However, the best route for nutrition, the optimal mix of nutrients, and the required duration of the therapy are unclear. This article will review the options for a nutritional care plan and provide practical tips for imple- menting and monitoring such a plan. INTRODUCTION fat and fat-soluble vitamins. As the name implies, the he lymph system is a complex and integral network lymph system carries lymph, comprised of white blood of lymph vessels and organs throughout the body. cells (primarily lymphocytes) and chyle from the GI T The lymph system includes the lymph vessels and tract, throughout the body. Chyle (from the Latin word capillaries, the thoracic duct, lymph nodes, the spleen, for “juice”) contains fat, as well as protein, electrolytes, thymus, bone marrow and gut associated lymphoid tis- lymphocytes, and other substances. sue (GALT), as well as other structures. The primary The incidence of chyle leaks is low, however, when functions of the lymph system include its immunological they do occur, they can be difficult to manage and treat. role, the absorption of excess interstitial fluid and its A chyle leak may manifest in a variety of ways—as a chylothorax (chylous effusion) into the thoracic cavity, return to the bloodstream, and the transport of long chain as a chyloperitoneum (chylous ascites) into the Stacey McCray RD, Nutrition Support Specialist, abdomen, as a chylopericardium around the heart, or as Consultant and Carol Rees Parrish MS, RD, Nutrition an external draining fistula. -
PICTORIAL REVIEW Thoracic Involvement in Connective
JBR–BTR, 2015, 98: 3-19. PICTORIAL REVIEW THORACIC INVOLVEMENT IN CONNECTIVE TISSUE DISEASES: RADIO- LOGICAL PATTERNS AND FOLLOW-UP G. Serra1, A.-L. Brun1, P. Ialongo2, M.-L. Chabi1, P.A. Grenier1 Connective tissue diseases (CTDs) are a heterogeneous group of idiopathic inflammatory diseases involving various organs. A thoracic involvement is frequent, and chest-CT represents the imaging technique of reference in its assess- ment. Pulmonary abnormalities related to CTDs are various; although several disease-specific aspects have been described, the two most clinically relevant complications are represented by interstitial lung disease and pulmonary arterial hypertension. The early identification of a thoracic involvement, with the adoption of specific therapies, can significantly change patient’s prognosis. The aim of this article is to review the most common typical and atypical CT features of thoracic involvement occurring in CT, especially focusing on interstitial lung disease. Key-word: Connective tissue, diseases – Lung, interstitial disease – Hypertension, pulmonary. Connective tissue diseases (CTDs) at the time of diagnosis of CTD, or chronic inflammation in the alveolar are a heterogeneous group of in- more commonly manifest later in the walls. The patients usually response flammatory diseases derived from course of the disease (5, 6). well to corticosteroid therapy and an immunologic deregulation affect- The most common histopatholog- have a good prognosis. However pa- ing various organs. A thoracic in- ic patterns of ILD seen in the setting tients with OP associated with CTD volvement (pulmonary, pleural or of CTDs are non specific interstitial seem to have a greater tendency to mediastinal) can be frequently pneumonia (NSIP), usual interstitial develop fibrosis and a higher mortal- found; its frequency and expression pneumonia (UIP), organizing pneu- ity than patients with cryptogenic depends on the type of disease, and monia (OP), diffuse alveolar damage OP (5, 6). -
Chylothorax As Rare Manifestation of Pleural Involvement in Waldenström Macroglobulinemia: Mechanisms and Management
210 Lymphology 49 (2016) 210-217 CHYLOTHORAX AS RARE MANIFESTATION OF PLEURAL INVOLVEMENT IN WALDENSTRÖM MACROGLOBULINEMIA: MECHANISMS AND MANAGEMENT G. Leoncini, C.C. Campisi, G. Fraternali Orcioni, F. Patrone, F. Ferrando, C. Campisi Unit of Thoracic Surgery (GL), Unit of General & Lymphatic Surgery - Microsurgery and Department of Surgical Sciences and Integrated Diagnostics (DISC) (CCC,CC), Unit of Pathology (GFO), Unit of Internal Medicine and Medical Oncology and Department of Internal Medicine (DIMI) (FP,FF), IRCCS San Martino University Hospital - National Institute for Cancer Research, and University School of Medicine and Pharmaceutics, Genoa, Italy ABSTRACT increase of IgM level. Pleuropulmonary involvement is reported to be rare (from 0 Here we report the clinical, pathological, to 5% of cases), and it usually occurs during and immunological features of a rare case of the late phase of the disease (3,4). In such a Waldenström macroglobulinemia (WM) with scenario, chylothorax is rarely observed in pleural infiltrations. An atypical chylothorax, WM patients; indeed only seven cases have successfully treated by videothoracoscopy, been reported in the literature (5-11). We represented the main clinical feature of this report the case of a 66-year old man with the case of low-grade lymphoplasmacytic main clinical presentation of pleural lymphoma. Pleuropulmonary manifestations infiltrations with right chylothorax following are rare (from 0 to 5% of cases) in WM, with immunochemotherapy. An extra-bone chylothorax observed in just seven patients marrow involvement was suggested by both worldwide. In addition to describing this pleural fluid examination and multiple uncommon clinical presentation, we investi- pleural biopsies in parallel with a marked gate hypothetical pathogenetic mechanisms decrease of bone marrow (BM) participation causing chylothorax and through an up-to- (tumor cells in BM from 70% to 8%). -
Management of Malignant Pleural Effusions an Official ATS/STS/STR Clinical Practice Guideline David J
AMERICAN THORACIC SOCIETY DOCUMENTS Management of Malignant Pleural Effusions An Official ATS/STS/STR Clinical Practice Guideline David J. Feller-Kopman*, Chakravarthy B. Reddy*, Malcolm M. DeCamp, Rebecca L. Diekemper, Michael K. Gould, Travis Henry, Narayan P. Iyer, Y. C. Gary Lee, Sandra Z. Lewis, Nick A. Maskell, Najib M. Rahman, Daniel H. Sterman, Momen M. Wahidi, and Alex A. Balekian; on behalf of the American Thoracic Society, Society of Thoracic Surgeons, and Society of Thoracic Radiology THIS OFFICIAL CLINICAL PRACTICE GUIDELINE WAS APPROVED BY THE AMERICAN THORACIC SOCIETY OCTOBER 2018, THE SOCIETY OF THORACIC SURGEONS JUNE 2018, AND THE SOCIETY OF THORACIC RADIOLOGY JULY 2018 Background: This Guideline, a collaborative effort from the MPE; 3) using either an indwelling pleural catheter (IPC) or American Thoracic Society, Society of Thoracic Surgeons, and chemical pleurodesis in symptomatic patients with MPE and Society of Thoracic Radiology, aims to provide evidence-based suspected expandable lung; 4) performing large-volume recommendations to guide contemporary management of patients thoracentesis to assess symptomatic response and lung expansion; with a malignant pleural effusion (MPE). 5) using either talc poudrage or talc slurry for chemical pleurodesis; 6) using IPC instead of chemical pleurodesis in patients with Methods: A multidisciplinary panel developed seven questions nonexpandable lung or failed pleurodesis; and 7) treating using the PICO (Population, Intervention, Comparator, and IPC-associated infections with antibiotics and not removing the Outcomes) format. The GRADE (Grading of Recommendations, catheter. Assessment, Development and Evaluation) approach and the Evidence to Decision framework was applied to each question. Recommendations Conclusions: These recommendations, based on the best available were formulated, discussed, and approved by the entire panel. -
Respiratory Function Changes After Asbestos Pleurisy
Thorax: first published as 10.1136/thx.35.1.31 on 1 January 1980. Downloaded from Thorax, 1980, 35, 31-36 Respiratory function changes after asbestos pleurisy P H WRIGHT, A HANSON, L KREEL, AND L H CAPEL From the Cardiothoracic Institute, London Chest Hospital, East Ham Chest Clinic, London, and the Division of Radiology, Clinical Research Centre, Northwick Park Hospital, Harrow ABSTRACT Six patients with radiographic evidence of diffuse pleural thickening after industrial asbestos exposure are described. Five had computed tomography of the thorax. All the scans showed marked circumferential pleural thickening often with calcification, and four showed no significant evidence of intrapulmonary fibrosis (asbestosis). Lung function testing showed reduc- tion of the inspiratory capacity and the single-breath carbon monoxide transfer factor (TLco). The transfer coefficient, calculated as the TLCO divided by the alveolar volume determined by helium dilution during the measurement of TLco, was increased. Pseudo-static compliance curves showed markedly more negative intrapleural pressures at all lung volumes than found in normal people. These results suggest that the circumferential pleural thickening was preventing normal lung expansion despite abnormally great distending pressures. The pattern of lung function tests is sufficiently distinctive for it to be recognised in clinical practice, and suggests that the lungs are held rigidly within an abnormal pleura. The pleural thickening in our patients may have been related to the condition described as "benign asbestos pleurisy" rather than the copyright. interstitial fibrosis of asbestosis. Malignant pleural effusion associated with meso- necessary in many of these early cases, and opera- thelioma or bronchial carcinoma is a recognised tion notes recorded the presence of marked http://thorax.bmj.com/ complication of asbestos exposure. -
Occupational Lung Diseases
24 Occupational lung diseases Introduction i Occupational diseases are often thought to be Key points uniquely and specifically related to factors in the work environment; examples of such diseases are • Systematic under-reporting and the pneumoconioses. However, in addition to other difficulties in attributing causation both contribute to underappreciation of the factors (usually related to lifestyle), occupational burden of occupational respiratory exposures also contribute to the development or diseases. worsening of common respiratory diseases, such • Work-related exposures are estimated as chronic obstructive pulmonary disease (COPD), to account for about 15% of all adult asthma and lung cancer. asthma cases. • Boththe accumulation of toxic dust in the Information about the occurrence of occupational lungs and immunological sensitisation respiratory diseases and their contribution to to inhaled occupational agents can morbidity and mortality in the general population is cause interstitial lung disease. provided by different sources of varying quality. Some • Despite asbestos use being phased European countries do not register occupational out, mesothelioma rates are forecast diseases and in these countries, information about to continue rising owing to the long latency of the disease. the burden of such diseases is completely absent. • The emergence of novel occupational In others, registration is limited to cases where causes of respiratory disease in compensation is awarded, which have to fulfil specific recent years emphasises the need for administrative or legal criteria as well as strict continuing vigilance. medical criteria; this leads to biased information and underestimation of the real prevalence. Under- reporting of occupational disease is most likely to occur in older patients who are no longer at work but whose condition may well be due to their previous job. -
Chyle Leak Post Laparoscopic Cholecystectomy: a Case Report, Literature Review and Management Options
7 Case Report Page 1 of 7 Chyle leak post laparoscopic cholecystectomy: a case report, literature review and management options Ferdinand Ong1, Amitabha Das1, Kheman Rajkomar2 1Department of Upper Gastrointestinal Surgery, Liverpool Hospital, Sydney, NSW, Australia; 2Department of Upper Gastrointestinal Surgery, Bankstown-Lidcombe Hospital, Sydney, NSW, Australia Correspondence to: Dr. Kheman Rajkomar. Eldridge Road, Bankstown-Lidcombe Hospital, Bankstown NSW 2200, Sydney, Australia. Email: [email protected]. Abstract: Chyle leak after a laparoscopic cholecystectomy (LC) is very rarely reported. However, it is needs to be recognised promptly and managed as otherwise it can lead to further metabolic and infective complications. We present the case of a 48 years old man who was admitted with ultrasound proven acute calculous cholecystitis. His vital signs were within normal range but his murphy’s sign was positive. His white cell count (WCC) and liver function tests were within normal limit. He underwent an uneventful standard LC with cholangiography during the same admission with no anomalous biliary or hepatic arterial anatomy noted during the procedure. Post operatively he was noted to have 125 mL of white fluid in his drain. The fluid triglyceride was 23.2 mmol/L, cholesterol level was 2.8 mmol/L, and drain/serum triglyceride of 15.5, hence confirming it to be chyle. He was clinically otherwise very well. He was managed conservatively as a low volume chyle leak with a fat free diet. The triglyceride content in the drain effluent decreased to 1.3mmol/L by day 6 and the fluid turned straw coloured in that interval. The drain was removed and the patient discharged home without any further issues. -
Thoracic Ultrasound in the Diagnosis of Malignant Pleural Effusion
Pleural disease Thoracic ultrasound in the diagnosis of malignant Thorax: first published as 10.1136/thx.2008.100545 on 13 October 2008. Downloaded from pleural effusion N R Qureshi,1 N M Rahman,2 F V Gleeson3 See Editorial, p 97 ABSTRACT criteria established in previous studies.12 13 CECT is Background: Malignant pleural effusion (MPE) is a c Additional details of the recommended as the next investigation, with a techniques, statistical analysis common clinical problem with described investigation view to subsequent histological diagnosis (blind, and figures are published online pathways. While thoracic ultrasound (TUS) has been image-guided or thoracoscopic pleural biopsy).414 only at http://thorax.bmj.com/ shown to be accurate in pleural fluid detection, its use in Thoracic ultrasound (TUS) is a valuable clinical content/vol64/issue2 the diagnosis of malignant pleural disease has not been tool which is increasingly being performed by chest 1 Department of Radiology, assessed. A study was undertaken to assess the physicians. In the UK, guidelines have recently Papworth Hospital NHS diagnostic accuracy of TUS in differentiating malignant been published with suggested training for physi- Foundation Trust, Papworth 15 Everard, Cambridge, UK; and benign pleural disease. cians with an interest in practising TUS. 2 Oxford Centre for Respiratory Methods: 52 consecutive patients with suspected MPE Hitherto, the role of TUS has been limited to Medicine and University of underwent TUS and contrast-enhanced CT (CECT). TUS pleural fluid detection (with high sensitivity) and Oxford, Oxford Radcliffe was used to assess pleural surfaces using previously image-guided techniques (thoracocentesis, drain Hospital, Oxford, UK; placement, lung biopsy).14 3 Department of Radiology, published CT imaging criteria for malignancy, diaphrag- Oxford Radcliffe Hospital, matic thickness/nodularity, effusion size/nature and The sonographic appearance of malignant Oxford, UK presence of hepatic metastasis (in right-sided effusions). -
Pulmonary and Tracheobronchial Amyloidosis
Pulmonary and Tracheobronchial Amyloidosis John L. Berk, M.D.,1,2,3 Anthony O’Regan, M.D.,1,3 and Martha Skinner, M.D.2,3 ABSTRACT Amyloidosis is a collection of diseases in which different proteins are deposited as insoluble -pleated sheets, disrupting organ function. Each precursor protein induces a separate spectrum of organ involvement, and different disease manifestations within the lung. Although autopsy data often demonstrate amyloid deposits in various compart- ments of the lung, few of the pathologic findings are expressed clinically. We review the pulmonary pathology, radiology, clinical presentations, and treatment options for each of the major systemic and localized forms of amyloidosis. This review focuses on amyloid derived from immunoglobulin light-chain protein (AL disease), which most frequently involves the lung in both systemic and localized forms of the disease. Manifestations of AL-related lung disease range from nodules identified on incidental chest films to diffuse alveolar+–septal deposition mimicking diffuse alveolar damage. We discuss respiratory failure due to diaphragm invasion, proximal tracheal disease, and diffuse alveolar–septal deposition. Guidelines for evaluation of patients with amyloid are presented. KEYWORDS: Amyloidosis, tracheobronchial amyloidosis, lung diseases Objectives: Upon completion of this article, the reader will understand the importance of amyloid fiber type on the spectrum of pul- monary manifestations and the natural course of disease in patients with systemic amyloidosis. Accreditation: The University of Michigan is accredited by the Accreditation Council for Continuing Medical Education to sponsor continuing medical education for physicians. Credits: The University of Michigan designates this educational activity for a maximum of 1.0 hour in category one credits toward the AMA Physicians Recognition Award. -
Chylothorax Or Leakage of Total Parenteral Nutrition?
Copyright ©ERS Journals Ltd 1998 Eur Respir J 1998; 12: 1233–1235 European Respiratory Journal DOI: 10.1183/09031936.98.12051233 ISSN 0903 - 1936 Printed in UK - all rights reserved CASE STUDY Chylothorax or leakage of total parenteral nutrition? A. Wolthuis*, R.B.M. Landewé**, P.H.M.H. Theunissen***, L.W.J.J.M. Westerhuis* aa Chylothorax or leakage of total parenteral nutrition? A. Wolthuis, R.B.M. Landewé, Depts of *Clinical Chemistry, **Rheuma- P.H.M.H. Theunissen, L.W.J.J.M. Westerhuis. ©ERS Journals Ltd 1998. tology and ***Clinical Pathology, Het ABSTRACT: The diagnosis chylothorax is based on a chemical analysis of the pleural Atrium Medisch Centrum, Heerlen, The effusion. According to the literature, this analysis can be rather straightforward, Netherlands. comprising measurements of triglycerides, chylomicrons, and cholesterol. In this Correspondence: A. Wolthuis, Dept of report we present an autopsy case that alerted us to interpret these results critically. Clinical Chemistry, Atrium, Medical Cen- Although the laboratory tests of the pleural effusion in this patient with parenteral tre, Heerlen, HenriDunantstraat 5, 6419 nutrition suggested chylothorax, additional tests (potassium (11.3 mmol·L-1) and glu- PC Heerlen, The Netherlands. Fax: 31 455766255 cose (128 mmol·L-1)) proved otherwise. Comparison of the pleural effusion analysis and the content of the parenteral nutrition led to the final conclusion that the effusion Keywords: Chylothorax, pleural effusion, was due to a leakage of parenteral nutrition instead of chylothorax. We therefore sug- total parenteral nutrition gest adding glucose and potassium measurements to the biochemical work-up of a Received: April 8 1998 patient under suspicion of chylothorax.